FENC · Healthcare · $370M
$10.65-1.39%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“PEDMARK의 핵심 성장 동력은 '페넥 HEARS'라는 환자 지원 프로그램이에요.”
In the company's words · 2026 1분기 earnings call